Aeon BiopharmaAEON
13F holders, Q2 2026 (June 30)22holders −2
2new positions
4sold out
$0.72avg. 13F price*
At the end of Q2 2026, 22 institutions reported holding Aeon Biopharma Inc. (AEON) in their 13F filings, down 2 from Q1 2026. 2 opened new positions and 4 sold out. The largest holders were Dauntless Investment Group, LLC ($9.0M), Geode Capital Management, LLC ($69K) and Vanguard Capital Management LLC ($65K).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $15K |
| Exits | 4 | $36K |
All 13F filers, Q1 2026 → Q2 2026: 9,999,317 shares bought and 37,949 shares sold, net +9,961,368 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Dauntless Investment Group, LLC | 15.58% | Add +394.1% | 12,490,154 | $9.0M |
| Geode Capital Management, LLC | 0.00% | Add +9.5% | 95,311 | $69K |
| Vanguard Capital Management LLC | 0.00% | No change | 90,529 | $65K |
| Blue Owl Capital Holdings LP | 0.00% | No change | 42,353 | $30K |
| Formidable Asset Management, LLC | 0.00% | No change | 20,024 | $20K |
| StoneX Group Inc. | 0.00% | New | 18,953 | $15K |
| Vanguard Fiduciary Trust Co. | 0.00% | Reduce -6.7% | 13,713 | $10K |
| LPL Financial LLC | 0.00% | No change | 11,507 | $8K |
| Citigroup Inc. | 0.00% | Add +885.9% | 7,315 | $5K |
| UBS Group AG | 0.00% | Add +21.0% | 5,062 | $4K |
| BlackRock, Inc. | 0.00% | No change | 2,834 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +446.2% | 2,567 | $2K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,100 | $791 |
| Wolff Wiese Magana LLC | 0.00% | No change | 567 | $408 |
| SBI Securities Co., Ltd. | 0.00% | Add +121.0% | 232 | $167 |
| Dupont Capital Management Corp. | 0.01% | — | 170 | $122 |
| Morgan Stanley | 0.00% | No change | 150 | $108 |
| GHP Investment Advisors, Inc. | 0.00% | No change | 95 | $69 |
| Wells Fargo & Company | 0.00% | No change | 90 | $65 |
| Barclays PLC | 0.00% | New | 59 | $42 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| Caitong International Asset Management Co., Ltd | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is AEON's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.